CDSCO

CDSCO Releases Guidance Document on Medical Device Software

Posted by: Prabhas Chakraborty July 29, 2026

7
Comments Off on CDSCO Releases Guidance Document on Medical Device Software
29th July, 2026

Central Government Prohibits Manufacture, Sale, and Distribution of 16 Irrational Fixed Dose Combinations

Posted by: Hitesh Gupta July 27, 2026

Government Notifies Drugs (Tenth Amendment) Rules, 2026 Bringing High-Alcohol Oral Drug Formulations Under Schedule H1

Posted by: Prabhas Chakraborty July 23, 2026

CDSCO Invites Public Comments on Proposal for Brand Name Extensions in Pharmaceutical Products

Posted by: Prabhas Chakraborty July 14, 2026

Drugs (Ninth Amendment) Rules, 2026 – Inclusion of Navi Mumbai as Authorized Drug Import Airport.

Posted by: Hitesh Gupta July 9, 2026

CDSCO updated list of laboratories to conduct Performance evaluation of IVDs dated 29/06/2026

Posted by: Hitesh Gupta July 1, 2026

2026.06.23 G.S.R. 509(E)_ Draft notification regarding simplification of the process for obtaining test licences for import of drugs under Form 11 of the Drugs Rules, 1945

Posted by: Hitesh Gupta July 1, 2026

2026.06.23 515(E)_Draft notification regarding amendments under Medical Devices Rules 2017

Posted by: Hitesh Gupta July 1, 2026

What's New 2?

Regulation/Guidelines

How to Build an Indian Regulatory Strategy for Advanced Biologicals Before Entering the Market

The decision to enter the Indian market with an advanced Biological product should be made with a comprehensive regulatory strategy in place. India's multi-authority regulatory environment, distinct clinical data requirements,...

7th August, 2026

Regulation/Guidelines

AI in Regulatory Affairs and Clinical Development: What Pharmaceutical Companies Need to Know in 2026

Artificial intelligence is reshaping Pharmaceutical research and development, regulatory affairs, and clinical operations at a pace that few industries have previously experienced. From AI-accelerated drug discovery and predictive Clinical Trial...

6th August, 2026

Regulation/Guidelines

India as a Cosmetic Manufacturing Hub: CDSCO, BIS, and the Regulatory Enablers for Global Manufacturers

The Strategic Shift For most global Cosmetic brands, India's regulatory journey has begun with import registration — the COS-2 pathway explored throughout this series. But for a growing cohort of...

5th August, 2026

Regulation/Guidelines

Post-Market Surveillance Under Medical Device Rules, 2017

Regulatory approval is often treated as the finish line. In reality, for Medical Device and IVD manufacturers in India, it marks the start of an equally demanding obligation: Post-Market Surveillance...

4th August, 2026

CDSCO

CDSCO

CDSCO Releases Guidance Document on Medical Device Software

Central Government Prohibits Manufacture, Sale, and Distribution of 16 Irrational Fixed Dose Combinations

Government Notifies Drugs (Tenth Amendment) Rules, 2026 Bringing High-Alcohol Oral Drug Formulations Under Schedule H1

CDSCO Invites Public Comments on Proposal for Brand Name Extensions in Pharmaceutical Products

Drugs (Ninth Amendment) Rules, 2026 – Inclusion of Navi Mumbai as Authorized Drug Import Airport.

CDSCO updated list of laboratories to conduct Performance evaluation of IVDs dated 29/06/2026

2026.06.23 G.S.R. 509(E)_ Draft notification regarding simplification of the process for obtaining test licences for import of drugs under Form 11 of the Drugs Rules, 1945

2026.06.23 515(E)_Draft notification regarding amendments under Medical Devices Rules 2017

For Importers To India

Drug

Biologicals

Food Supplements

Medical Device

IVD

Food

Cosmetic

Other

For Manufacturer in India

Drug

Biologicals

Food Supplements

Food

Medical Device

IVD

Cosmetic

Other